Carcinotech

Organo-ID

The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.

Xilis

Xilis develops miniature patient-derived tumour models for precision oncology and drug discovery, serving clinicians and pharmaceutical companies.

BioSapien

This company develops 3D-printed biodegradable mesh for localized and sustained delivery of chemotherapy drugs to cancer patients.

Iscaff Pharma

This company develops patient-derived tumor scaffolds for pharmaceutical firms to improve the pre-clinical validation and development of aggressive cancer treatments.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.

ScreenIn3D Limited

This company develops microfluidic lab-on-a-chip platforms for drug developers to test therapies on patient-derived three-dimensional tumour samples.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

Cellbricks

Cellbricks develops 3D-bioprinted human tissue implants and vascularised therapeutics for patients with complex wounds, soft tissue defects and organ damage.